A5066500109- Hair Growth and Disorders
- Dermatologic Treatments and Research
- Autoimmune Bullous Skin Diseases
- Genetic and rare skin diseases.
- Dermatology and Skin Diseases
- RNA regulation and disease
- Dermatological and Skeletal Disorders
- Autoimmune and Inflammatory Disorders
- Skin and Cellular Biology Research
- melanin and skin pigmentation
- Drug-Induced Adverse Reactions
- Cancer and Skin Lesions
- Diagnosis and Treatment of Venous Diseases
- Child Abuse and Related Trauma
- Fetal and Pediatric Neurological Disorders
- Cutaneous lymphoproliferative disorders research
- Wound Healing and Treatments
- Vascular Malformations and Hemangiomas
- Connective tissue disorders research
- Urticaria and Related Conditions
- Physical Education and Sports Studies
Sinclair Dermatology
2020-2024
Florida International University
2021
The University of Melbourne
2021
Universidade Federal Fluminense
2018
Universidade Federal do Estado do Rio de Janeiro
2015
Abstract Background Alopecia areata (AA) is an autoimmune hair loss condition that affects people of all ages. Early age onset and prolonged disease duration indicate poor prognosis. Janus kinase inhibitors are being investigated in phase 3 clinical trials adolescents adults with AA Objective To evaluate the use oral tofacitinib pre‐adolescent patients AA. Methods A retrospective review case records treated a single center between 2018 2019. Results Fourteen were identified, aged 7 to 11...
Baricitinib is a Janus kinase inhibitor that has been approved by the US Food and Drugs Administration for treatment of severe alopecia areata (AA) in adults. However, clinical trials demonstrated efficacy baricitinib AA did not include men aged > 60 years or women 70 years. We retrospectively assessed safety 14 patients ≥ 65 with moderate-to-severe AA. After mean (SD) duration 18.5 (11.9) months, 72% reduction Severity Alopecia Tool score from baseline was observed. Partial complete eyebrow...
Lichen planopilaris (LPP) and frontal fibrosing alopecia (FFA) are lymphocytic, cicatricial alopecias. Clinically, LPP presents with multifocal patchy alopecia, while FFA, considered a variant of LPP, results in hairline recession. Frontal recession FFA may progress as far the mid-scalp infrequently beyond. Treatment to arrest inflammatory process can be challenging response variable. We report case recalcitrant lichen demonstrating significant clinical improvement after four doses...
Abstract Alopecia areata has various clinical presentations, some of which have recognised prognostic significance. We report five cases bitemporal alopecia areata, with involvement the frontal hairline, therapeutic approach for each case and possible differential diagnoses to also consider.
Alopecia areata (AA) is an autoimmune nonscarring alopecia that has variable clinical patterns, most commonly patchy disease. We report a case of AA with unusual involvement the frontal hairline, mimicking fibrosing (FFA), form scarring alopecia. Dermoscopic findings and response to treatment favored diagnosis AA. These highlight major role trichoscopy as well importance including in differential for FFA.
Alopecia areata (AA) ist eine autoimmune, nicht vernarbende Alopezie mit unterschiedlichen klinischen Mustern, am häufigsten fleckenhaft auftretende Veränderung. Wir berichten über einen Fall von AA ungewöhnlicher Beteiligung des frontalen Haaransatzes, ähnlich der fibrosierenden (FFA), einer Form vernarbenden Alopezie. Dermatoskopische Befunde und das Ansprechen auf die Behandlung favorisierten Diagnose AA. Diese Ergebnisse unterstreichen große Rolle Trichoskopie sowie Bedeutung...
A 37-year-old man presented with a progressively pruritic and pustular eruption on the face of 2 weeks' duration.Twenty days prior to rash onset, he began treatment for scalp psoriasis mixture salicylic acid 20 mg/mL betamethasone dipropionate 0.5 mg/mL, which inadvertently extended facial area.One week after emergency department at local hospital, where was given intravenous hydrocortisone 100 mg no improvement rash.He had history skin cancer, his family negative dermatologic disease.At...